½ÃÀ庸°í¼­
»óǰÄÚµå
1618683

¼¼°èÀÇ Àúħ½À ¼ö¼ú ½ÃÀå : À¯Çü, ±â¼ú, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Minimally Invasive Surgery Market by Type (Cardiovascular Surgery, Cosmetic Surgery, Gastrointestinal Surgery), Technology (Endoscopic Surgery, Laparoscopy, Laser & Microsurgery), End Users - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 188 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Àúħ½À ¼ö¼ú ½ÃÀåÀº 2023³â¿¡ 719¾ï 6,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 812¾ï 1,000¸¸ ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç CAGR 13.28%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 1,723¾ï 7,000¸¸ ´Þ·¯·Î µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Àúħ½À ¼ö¼ú(MIS)Àº ÀÛÀº Àý°³¿Í º¹°­°æ°ú ³»½Ã°æ°ú °°Àº °í±Þ µµ±¸¸¦ »ç¿ëÇÏ¿© Á¶Á÷ ¿Ü»óÀ» ÃÖ¼ÒÈ­Çϵµ·Ï ¼³°èµÈ ¼ö¼ú ÀýÂ÷¸¦ Æ÷ÇÔÇÕ´Ï´Ù. ÀÔ¿ø ±â°£ ´ÜÃà, ȸº¹ ¼Óµµ, ¼ö¼ú ³ªÁß¿¡ ÅëÁõ ¿ÏÈ­¿Í °°Àº ÀåÁ¡¿¡¼­ ÇÊ¿äÇÏ¸ç ½ÉÀå ¼ö¼ú¿¡¼­ Á¤Çü¿Ü°ú ¼ö¼ú±îÁö Á¡Á¡ ´õ Àû¿ëµÇ°í ÀÖÀ¸¸ç ÃÖÁ¾ ¿ëµµ ½Ã¼³¿¡´Â ÁÖ·Î º´¿ø, Àü¹® Ŭ¸®´Ð ¹× ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)°¡ ÀÖÀ¸¸ç MIS ±â¼ú ¼ö¼úÀÇ Ã¤Åà Ȯ´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎÀº ¼ö¼ú±â±¸ÀÇ ±â¼úÀû Áøº¸, ¼ö¼úÀû °³ÀÔÀÌ ÇÊ¿äÇÑ ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, ȯÀÚ ¼±È£ ¹× ºñ¿ë È¿À²¼º¿¡ ÀÇÇÑ ¿Ü·¡ ¼ö¼ú ¼ö¿ä Áõ°¡ÀÔ´Ï´Ù. Áõ°­Çö½Ç°ú °°Àº Çõ½ÅÀûÀÎ ±â¼ú¿¡ ´ëÇÑ R & D ÅõÀÚ Áõ°¡´Â ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ´Â ÀΰøÁö´É°ú µ¥ÀÌÅÍ ºÐ¼®À» ÅëÇÕÇÏ¿© MIS ¼ö¼úÀÇ Á¤È®¼º°ú Ä¡·á ¼ºÀû Çâ»ó ±×·¯³ª ÀåºñÀÇ ¸ê±Õ¿¡ ´ëÇÑ ¿ì·Á ¿Ü¿¡µµ Ãʱâ ÅõÀÚ ºñ¿ëÀÇ ³ôÀÌ¿Í ¼ö¼ú Àü¹®°¡ÀÇ ÇнÀ °î¼±ÀÇ ¾î·Á¿òÀÌ ½ÃÀå ¼ºÀåÀÇ ÀáÀçÀû Á¦¾àÀ̵Ǿú½À´Ï´Ù. ÀÇ·á Á¦°øÀÚ¿ÍÀÇ Àü·«Àû Á¦ÈÞ°¡ Çõ½ÅÀ» ÃËÁøÇÏ°í ¿Ü°úÀÇ»çÀÇ ±³À° ÇÁ·Î±×·¥À» °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¼ú È¿À²¼ºÀ» ³ôÀ̱â À§ÇØ ½Ç½Ã°£ À̹Ì¡ ±â¼úÀ» °³¼±ÇÏ´Â µ¥ ÁßÁ¡À» µÑ ¼ö ÀÖ½À´Ï´Ù. MIS ½ÃÀåÀº ȯÀÚ Áß½ÉÀÇ ÀÇ·á·ÎÀÇ ½ÃÇÁÆ®¸¦ ¹Ý¿µÇÑ ¿ªµ¿ÀûÀÎ ½ÃÀåÀ̸ç, ÇöÀç ÁøÇàÁßÀÎ °úÁ¦¿¡ ´ëóÇϸ鼭 ±â¼ú Çõ½Å°ú ±â¼ú Áøº¸¿¡ ÀûÀÀÇÒ ¼ö ÀÖ´Â ±â¾÷¿¡°Ô´Â Å« ¼ºÀå ±âȸµµ µË´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 719¾ï 6,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 812¾ï 1,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 1,723¾ï 7,000¸¸ ´Þ·¯
CAGR(%) 13.28%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â Àúħ½À ¼ö¼ú ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

Àúħ½À ¼ö¼ú ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ȹµæÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¶Ç´Â ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ÀÔ¿ø ±â°£ÀÇ ´ÜÃà¿¡ ´ëÇÑ È¯ÀÚÀÇ ±âÈ£
    • ¼¼°è °¢Áö¿¡¼­ÀÇ ¼ö¼ú¼¾ÅÍ, º´¿ø, Áø·á¼ÒÀÇ È®´ë
    • ÇコÄÉ¾î ¼­ºñ½ºÀÇ ÀÌ¿ë ¿ëÀ̼ºÀ» Çâ»ó½ÃÄÑ, Àúºñ¿ëÀ¸·Î ¼ö¼ú ¼Ö·ç¼ÇÀ» Á¦°øÇϱâ À§ÇÑ Á¤ºÎÀÇ ´ëó
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¼ö¼ú ±â±¸ÀÇ Ãë±ÞÀ̳ª Àúħ½À ¼ö¼úÀÇ ½ÇÇàÀÇ º¹À⼺
  • ½ÃÀå ±âȸ
    • ÷´Ü Àúħ½À ¼ö¼ú ¼Ö·ç¼Ç ¹× Àåºñ °³¹ßÀ» À§ÇÑ Áö¼ÓÀûÀÎ ¹ßÀü°ú ¿¬±¸ °³¹ß.
    • Àúħ½À ¼ö¼ú ±â±â ¹× ½Ã½ºÅÛÀÇ º¸±ÞÀ» Áö¿øÇÏ´Â ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ
  • ½ÃÀåÀÇ °úÁ¦
    • °¨¿° À§Çè°ú ¼ö¼ú ÀåºñÀÇ ºó¹øÇÑ À¯Áö º¸¼ö Çʿ伺

Porter's Five Force : Àúħ½À ¼ö¼ú ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Force Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÆÄ¾ÇÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸Àå ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Àúħ½À ¼ö¼ú ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Àúħ½À ¼ö¼ú ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹ÃøÇÒ ¼ö ÀÖ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ µÇ¾ú½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : Àúħ½À ¼ö¼ú ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

Àúħ½À ¼ö¼ú ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í, º¥´õ´Â °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«ÀûÀÎ ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö°ß À» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : Àúħ½À ¼ö¼ú ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Àúħ½À ¼ö¼ú ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÐÇÒÇϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå : Àúħ½À ¼ö¼ú ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

Àúħ½À ¼ö¼ú½ÃÀåÀÇ Àü·«ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ÀÔ¿ø±â°£ ´ÜÃà¿¡ ´ëÇÑ È¯ÀÚÀÇ Èñ¸Á
      • ¼¼°è¿¡¼­ ¿Ü°ú ¼¾ÅÍ, º´¿ø, Áø·á¼ÒÀÇ È®´ë
      • ÇコÄÉ¾î ¼­ºñ½ºÀÇ Á¢±Ù¼ºÀ» Çâ»ó½Ã۰í, º¸´Ù Àúºñ¿ëÀ¸·Î ¿Ü°úÀû ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â Á¤ºÎÀÇ ´ëó
    • ¾ïÁ¦¿äÀÎ
      • ¼ö¼ú ±â±¸ÀÇ Ãë±Þ°ú Àúħ½À ¼ö¼úÀÇ ½Ç½ÃÀÇ º¹À⼺
    • ±âȸ
      • ÷´Ü Àúħ½À ¼ö¼ú ¼Ö·ç¼Ç ¹× Àåºñ °³¹ßÀ» À§ÇÑ Áö¼ÓÀûÀÎ ¹ßÀü°ú Á¶»ç ÀÌ´Ï¼ÅÆ¼ºê
      • Àúħ½À ¼ö¼ú ±â±â ¹× ½Ã½ºÅÛÀÇ º¸±ÞÀ» Áö¿øÇÏ´Â ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ
    • °úÁ¦
      • °¨¿°ÀÇ À§Çè°ú ¼ö¼ú±â±¸ÀÇ ºó¹øÇÑ À¯Áö º¸¼öÀÇ Çʿ伺
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
    • À¯Çü : Á¤Çü¿Ü°ú ¼ö¼ú¿¡ Àúħ½À ¼ö¼úÀ» ä¿ëÇÏ¿© ÅëÁõÀ» ÁÙÀ̰í ȸº¹À» °¡¼ÓÈ­Çϰí ÈäÅ͸¦ ÃÖ¼ÒÈ­
    • ÃÖÁ¾ »ç¿ëÀÚ : ¼ö¼ú ÈÄ Áï½Ã Á¾ÇÕÀûÀÎ Äɾ Á¦°øÇÒ ¼ö Àֱ⠶§¹®¿¡ ¼¼°è º´¿ø¿¡¼­ µµÀÔ È®´ë
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå Àúħ½À ¼ö¼ú ½ÃÀå : À¯Çüº°

  • ½ÉÀåÇ÷°ü ¼ö¼ú
  • ¹Ì¿ë ¼ºÇü
  • ¼ÒÈ­±â ¼ö¼ú
  • ºÎÀΰú ¼ö¼ú
  • Á¤Çü¿Ü°ú
  • ºñ´¢±â°ú ¼ö¼ú

Á¦7Àå Àúħ½À ¼ö¼ú ½ÃÀå : ±â¼úº°

  • ³»½Ã°æ ¼ö¼ú
  • º¹°­°æ °Ë»ç
  • ·¹ÀÌÀú¿Í ¸¶ÀÌÅ©·Î ¼­Àú¸®
  • ·Îº¿ ¼ö¼ú

Á¦8Àå Àúħ½À ¼ö¼ú ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • º´¿ø
  • Àü¹® Ŭ¸®´Ð

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ Àúħ½À ¼ö¼ú½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Àúħ½À ¼ö¼ú ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Àúħ½À ¼ö¼ú ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • Stryker, ¿Ü¹Ý¸ð ¹ß ±³Á¤¿ëÀÇ ¼±ÁøÀûÀÎ PROstep MIS Lapidus ½Ã½ºÅÛÀ» ¹ßÇ¥
    • Ãß»óÁ·ÁöÁõ ±âÇü¿¡ ´ëÇÑ Çõ½ÅÀûÀÎ Àú ħ½À ¼Ö·ç¼Ç: Forma MedicalÀÇ OptimalHT
    • Orthofix, Àúħ½À ôÃß ¼ö¼ú¿ë °­È­ ³×ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛÀ» ¹ßÇ¥
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Abbott Laboratories
  • Arthrex, Inc.
  • B. Braun SE
  • Boston Scientific Corporation
  • Commed Corporation
  • Cook Group Incorporated by The Cooper Companies, Inc.
  • Danaher Corporation
  • FUJIFILM Corporation
  • GE HealthCare Technologies Inc.
  • Getinge AB
  • Hoya Corporation
  • Intuitive Surgical, Inc.
  • Johnson & Johnson Services, Inc.
  • Karl Storz SE & Co. KG
  • Koninklijke Philips NV
  • Livanova PLC
  • Medtronic plc
  • Olympus Corporation
  • Richard Wolf GmbH
  • Siemens Healthineers
  • Smith & Nephew plc
  • Stryker Corporation
  • Synaptive Medical Inc.
  • Teleflex Incorporated
  • Zimmer Biomet Holdings, Inc.
JHS 24.12.30

The Minimally Invasive Surgery Market was valued at USD 71.96 billion in 2023, expected to reach USD 81.21 billion in 2024, and is projected to grow at a CAGR of 13.28%, to USD 172.37 billion by 2030.

Minimally Invasive Surgery (MIS) involves surgical techniques designed to minimize tissue trauma, utilizing small incisions and advanced instruments like laparoscopes and endoscopes. This approach is necessitated by its benefits, including reduced hospital stays, faster recovery, and lesser post-operative pain, making it increasingly applicable in procedures ranging from cardiac to orthopedic surgeries. End-use facilities primarily include hospitals, specialized clinics, and ambulatory surgical centers, each contributing to the growing adoption of MIS technologies. Key growth factors are technological advancements in surgical instruments, an increasing prevalence of chronic diseases necessitating surgical intervention, and heightened demand for outpatient surgeries driven by patient preference and cost-efficiency. Increased investments in R&D for innovative technologies such as robotic-assisted systems and augmented reality further fuel market expansion. Emerging opportunities lie in integrating artificial intelligence and data analytics to enhance precision and outcomes in MIS procedures. However, challenges such as high initial investment costs and a steep learning curve for surgical professionals, in addition to concerns regarding equipment sterilization, are potential limitations to market growth. To overcome these, strategic partnerships between tech companies and healthcare providers can foster innovation and improve training programs for surgeons. As the market rapidly evolves, research can focus on developing cost-effective instruments and improving real-time imaging techniques to enhance procedural efficiency. Keeping abreast of regulatory changes and maintaining compliance can also mitigate the potential risks associated with technology adoption. The MIS market is dynamic, reflecting a shift towards patient-centric care, and presents significant opportunities for growth for players that can innovate and adapt to technological advancements while addressing ongoing challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 71.96 billion
Estimated Year [2024] USD 81.21 billion
Forecast Year [2030] USD 172.37 billion
CAGR (%) 13.28%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Minimally Invasive Surgery Market

The Minimally Invasive Surgery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Patient preference for reducing the duration of hospital stays
    • Expansion of surgical centers, hospitals, and clinics across the world
    • Government initiatives to improve the accessibility of healthcare services and provide surgical solutions at lower cost
  • Market Restraints
    • Complexities of handling surgical equipment and performing minimally invasive surgeries
  • Market Opportunities
    • Ongoing advancements and research initiatives to develop advanced minimally invasive surgical solutions and equipment
    • Regulatory approvals supporting the proliferation of minimally invasive surgical devices and systems
  • Market Challenges
    • Risk of infection and need for frequent maintenance of surgical equipment

Porter's Five Forces: A Strategic Tool for Navigating the Minimally Invasive Surgery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Minimally Invasive Surgery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Minimally Invasive Surgery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Minimally Invasive Surgery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Minimally Invasive Surgery Market

A detailed market share analysis in the Minimally Invasive Surgery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Minimally Invasive Surgery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Minimally Invasive Surgery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Minimally Invasive Surgery Market

A strategic analysis of the Minimally Invasive Surgery Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Minimally Invasive Surgery Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Arthrex, Inc., B. Braun SE, Boston Scientific Corporation, Conmed Corporation, Cook Group Incorporated by The Cooper Companies, Inc., Danaher Corporation, FUJIFILM Corporation, GE HealthCare Technologies Inc., Getinge AB, Hoya Corporation, Intuitive Surgical, Inc., Johnson & Johnson Services, Inc., Karl Storz SE & Co. KG, Koninklijke Philips N.V., Livanova PLC, Medtronic plc, Olympus Corporation, Richard Wolf GmbH, Siemens Healthineers, Smith & Nephew plc, Stryker Corporation, Synaptive Medical Inc., Teleflex Incorporated, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Minimally Invasive Surgery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Cardiovascular Surgery, Cosmetic Surgery, Gastrointestinal Surgery, Gynecological Surgery, Orthopedic Surgery, and Urological Surgery.
  • Based on Technology, market is studied across Endoscopic Surgery, Laparoscopy, Laser & Microsurgery, and Robotic Surgery.
  • Based on End Users, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Patient preference for reducing the duration of hospital stays
      • 5.1.1.2. Expansion of surgical centers, hospitals, and clinics across the world
      • 5.1.1.3. Government initiatives to improve the accessibility of healthcare services and provide surgical solutions at lower cost
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities of handling surgical equipment and performing minimally invasive surgeries
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements and research initiatives to develop advanced minimally invasive surgical solutions and equipment
      • 5.1.3.2. Regulatory approvals supporting the proliferation of minimally invasive surgical devices and systems
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of infection and need for frequent maintenance of surgical equipment
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Adoption of minimally invasive surgeries for orthopedic procedures to ensure less pain, quicker recovery, and minimal scarring
    • 5.2.2. End Users: Expansion of hospitals across the world owing to their capacity to provide immediate, comprehensive post-operative care
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Minimally Invasive Surgery Market, by Type

  • 6.1. Introduction
  • 6.2. Cardiovascular Surgery
  • 6.3. Cosmetic Surgery
  • 6.4. Gastrointestinal Surgery
  • 6.5. Gynecological Surgery
  • 6.6. Orthopedic Surgery
  • 6.7. Urological Surgery

7. Minimally Invasive Surgery Market, by Technology

  • 7.1. Introduction
  • 7.2. Endoscopic Surgery
  • 7.3. Laparoscopy
  • 7.4. Laser & Microsurgery
  • 7.5. Robotic Surgery

8. Minimally Invasive Surgery Market, by End Users

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals
  • 8.4. Specialty Clinics

9. Americas Minimally Invasive Surgery Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Minimally Invasive Surgery Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Minimally Invasive Surgery Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Stryker Introduces Advanced PROstep MIS Lapidus System for Bunion Correction
    • 12.3.2. Innovative Minimally Invasive Solution for Hammertoe Deformities: Forma Medical's OptimalHT
    • 12.3.3. Orthofix Unveils Enhanced Navigation System for Minimally Invasive Spine Surgery
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Arthrex, Inc.
  • 3. B. Braun SE
  • 4. Boston Scientific Corporation
  • 5. Conmed Corporation
  • 6. Cook Group Incorporated by The Cooper Companies, Inc.
  • 7. Danaher Corporation
  • 8. FUJIFILM Corporation
  • 9. GE HealthCare Technologies Inc.
  • 10. Getinge AB
  • 11. Hoya Corporation
  • 12. Intuitive Surgical, Inc.
  • 13. Johnson & Johnson Services, Inc.
  • 14. Karl Storz SE & Co. KG
  • 15. Koninklijke Philips N.V.
  • 16. Livanova PLC
  • 17. Medtronic plc
  • 18. Olympus Corporation
  • 19. Richard Wolf GmbH
  • 20. Siemens Healthineers
  • 21. Smith & Nephew plc
  • 22. Stryker Corporation
  • 23. Synaptive Medical Inc.
  • 24. Teleflex Incorporated
  • 25. Zimmer Biomet Holdings, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦